{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:04:35Z","timestamp":1649189075329},"reference-count":57,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.150","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T22:05:21Z","timestamp":1437602721000},"page":"150-156","source":"Crossref","is-referenced-by-count":0,"title":["Using proteomic and genomic methods to understand JDM"],"prefix":"10.2177","volume":"38","author":[{"given":"Rie","family":"KARASAWA","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Genetics, Genomics & Bioinformatics Program, University at Buffalo"},{"name":"Department of Frontier Medicine, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N.","family":"JARVIS","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Genetics, Genomics & Bioinformatics Program, University at Buffalo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ernste, F.C., Reed, A.M.: Recent advances in juvenile idiopathic inflammatory myopathies. Curr Opin Rheumatol.<\/i> 26<\/b>: 671-678, 2014.","DOI":"10.1097\/BOR.0000000000000103"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Rider, L.G., et al.: Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am.<\/i> 39<\/b>: 877-904, 2013.","DOI":"10.1016\/j.rdc.2013.06.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shah, M., et al.: The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine<\/i> (Baltimore) 92<\/b>: 25-41, 2013.","DOI":"10.1097\/MD.0b013e31827f264d"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) McCann, L.J., et al.: The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)-clinical characteristics of children recruited within the first 5 yr. Rheumatology<\/i> (Oxford) 45<\/b>: 1255-1260, 2006.","DOI":"10.1093\/rheumatology\/kel099"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Robinson, A.B., et al.: Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res<\/i> (Hoboken) 66<\/b>: 404-410, 2014.","DOI":"10.1002\/acr.22142"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mendez, E.P., et al.: US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum.<\/i> 49<\/b>: 300-305, 2003.","DOI":"10.1002\/art.11122"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kobayashi, S., et al.: Characteristics of juvenile dermatomyositis in Japan. Acta Paediatr Jpn.<\/i> 39<\/b>: 257-262, 1997.","DOI":"10.1111\/j.1442-200X.1997.tb03595.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Rider, L.G., et al.: Textbook of Pediatric Rheumatology. 6th ed. Elsevier Saunders, Philadelphia, 375-413, 2011.","DOI":"10.1016\/B978-1-4160-6581-4.10024-X"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ravelli, A., et al.: Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res<\/i> (Hoboken) 62<\/b>: 63-72, 2010.","DOI":"10.1002\/acr.20015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Christen-Zaech, S., et al.: Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum.<\/i> 58<\/b>: 571-576, 2008.","DOI":"10.1002\/art.23299"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Faller, G., et al.: Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J.<\/i> 12<\/b>: 2012.","DOI":"10.1186\/1546-0096-12-2"},{"key":"12","unstructured":"12) Yu, H.H., et al.: Detection of anti-p155\/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis. J Microbiol Immunol Infect.<\/i> 14<\/b>: S1684-1182, 2014."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Targoff, I.N., et al.: A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum.<\/i> 54<\/b>: 3682-3689, 2006.","DOI":"10.1002\/art.22164"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fujimoto, M., et al.: Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum.<\/i> 64<\/b>: 513-522, 2012.","DOI":"10.1002\/art.33403"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gunawardena, H., et al.: Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology<\/i> (Oxford) 47<\/b>: 324-328, 2008.","DOI":"10.1093\/rheumatology\/kem359"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ichimura, Y., et al.: Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis.<\/i> 71<\/b>: 710-713, 2012.","DOI":"10.1136\/annrheumdis-2011-200697"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Gunawardena, H., et al.: Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum.<\/i> 60<\/b>: 1807-1814, 2009.","DOI":"10.1002\/art.24547"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hoshino, K., et al.: Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology<\/i> (Oxford) 49<\/b>: 1726-1733, 2010.","DOI":"10.1093\/rheumatology\/keq153"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Rider, L.G., et al.: The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myoathies. Medicine<\/i> (Baltimore) 92<\/b>: 223-243, 2013.","DOI":"10.1097\/MD.0b013e31829d08f9"},{"key":"20","unstructured":"20) Kobayashi, N., et al.: Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology<\/i> (Oxford). 2014 Oct 6. pii: keu385. [Epub ahead of print]"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tansley, S.L., et al.: UK Juvenile Dermatomyositis Research Group.Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther.<\/i> 16<\/b>: R138, 2014.","DOI":"10.1186\/ar4600"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Belizna, C., et al.: Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis.<\/i> 12<\/b>: 1545-1550, 2006.","DOI":"10.1136\/ard.2005.035295"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Karasawa, R., et al.: Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol.<\/i> 161<\/b>: 459-470, 2010.","DOI":"10.1111\/j.1365-2249.2010.04218.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Domiciano, D.S., et al.: Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus.<\/i> 18<\/b>: 1233-1238, 2009.","DOI":"10.1177\/0961203309346654"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Yang, Y.H., et al.: The immunobiology of Henoch-Sch\u00f6nlein purpura. Autoimmun Rev.<\/i> 7<\/b>: 179-184, 2008.","DOI":"10.1016\/j.autrev.2007.11.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wedderburn, L.R., Rider, L.G.: Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol.<\/i> 23<\/b>: 665-678, 2009.","DOI":"10.1016\/j.berh.2009.07.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Navarro, M., et al.: Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus.<\/i> 6<\/b>: 521-526, 1997.","DOI":"10.1177\/096120339700600608"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ayd\u00ecntug, A.O., et al.: Antibodies to endothelial cells in patients with Beh\u00e7et's disease. Clin Immunol Immunopathol.<\/i> 67<\/b>: 157-162, 1993.","DOI":"10.1006\/clin.1993.1059"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Yang, Y.H., et al.: The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Sch\u00f6nlein purpura. Clin Exp Immunol.<\/i> 130<\/b>: 352-357, 2002.","DOI":"10.1046\/j.1365-2249.2002.01964.x"},{"key":"30","unstructured":"30) Park, M.C., et al.: Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu's arteritis: correlations of their titers and isotype distributions with disease activity. Clin Exp Rheumatol.<\/i> 24<\/b>: S10-6, 2006."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Fujieda, M., et al.: A novel anti-peroxiredoxin autoantibody in patients with Kawasaki disease. Microbiol Immunol.<\/i> 56<\/b>: 56-61, 2012.","DOI":"10.1111\/j.1348-0421.2011.00393.x"},{"key":"32","unstructured":"32) Karasawa, R.: Progress and Clinical Applications in Proteomics. Journal of Data Mining in Genomics & Proteomics.<\/i> S1<\/b>: 1-6, 2012."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Karasawa, R., et al.: Anti-endothelial cell antibodies (AECA) in patients with systemic vasculitis: our research using proteomics. Expert Opin Biol Ther.<\/i> 11<\/b>: 77-87, 2011.","DOI":"10.1517\/14712598.2011.540234"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) De Franceschi, L., et al.: Proteome analysis of biological fluids from autoimmune-rheumatological disorders. Proteomics Clin Appl.<\/i> 5<\/b>: 78-89, 2011.","DOI":"10.1002\/prca.201000069"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) O'Hanlon, T.P., et al.: Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases. Arthritis Res Ther.<\/i> 13<\/b>: R181, 2011.","DOI":"10.1186\/ar3506"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Reed, A.M.: Myositis in children. Curr Op Rheumatol.<\/i> 13<\/b>: 428-433, 2001.","DOI":"10.1097\/00002281-200109000-00015"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Reed, A.M., Sterling, J.: The HLA-DQA1*0501 allele in juvenile dermatomyositis as seen in multiple racial groups. Hum Immunol.<\/i> 44<\/b>: 131-135, 1995.","DOI":"10.1016\/0198-8859(95)00035-6"},{"key":"38","unstructured":"38) Reed, A.M., et al.: Immunogentic studies in families of children with juvenile dermatomyositis. J Rheumatol.<\/i> 25<\/b>: 1000-1002, 1998."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Pachman, L.M., et al.: TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum.<\/i> 43<\/b>: 2368-2377, 2000.","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Pachman, L.M., et al.: Juvenile dermatomyositis: the association of the TNF alpha-308 allele and disease chronicity. Curr Rheumatol Reports.<\/i> 3<\/b>: 379-386, 2001.","DOI":"10.1007\/s11926-996-0007-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Jarvis, J.N.: Mechanisms of pathogenesis and inflammation in the pediatric rheumatic diseases. Curr Opin Rheumatol.<\/i> 10<\/b>: 459-467, 1998.","DOI":"10.1097\/00002281-199809000-00011"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Hinks, A., et al.: Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nature Genet.<\/i> 45<\/b>: 644-669, 2013.","DOI":"10.1038\/ng.2614"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Maurano, M., et al.: Systematic localization of common disease-associated variation in regulatory DNA. Science.<\/i> 337<\/b>: 1190-1195, 2012.","DOI":"10.1126\/science.1222794"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Jiang, K.*, et al.: Disease-associated SNPs from non-coding regions in juvenile idiopathic arthritis are located within or adjacent to functional genomic elements of human neutrophils and CD4+ T cells. Arthritis Rheum.<\/i> 2015; In press. * These authors contributed equally to this work.","DOI":"10.1002\/art.39135"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Kiezun, A., et al.: Exome sequencing and the genetic basis of complex traits. Nature Genet.<\/i> 44<\/b>: 623-630, 2012.","DOI":"10.1038\/ng.2303"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Jarvis, J.N., et al.: Gene expression profiling in pediatric rheumatic disease: What have we learned? What can we learn? Curr Prob Rheum.<\/i> 17<\/b>: 606-611, 2005.","DOI":"10.1097\/01.bor.0000171212.42252.d1"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Rosenfeld, S.: Do DNA microarrays tell the story of gene expression? Gene Regul Syst Bio.<\/i> 4<\/b>: 61-73, 2010.","DOI":"10.4137\/GRSB.S4657"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Tezak, Z., et al.: Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol.<\/i> 168<\/b>: 4154-4163, 2002.","DOI":"10.4049\/jimmunol.168.8.4154"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Chen, Y.-W., et al.: Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol.<\/i> 9<\/b>: 43, 2008.","DOI":"10.1186\/1471-2172-9-43"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Baechler, E.C., et al.: An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med.<\/i> 13<\/b>: 59-68, 2007.","DOI":"10.2119\/2006-00085.Baechler"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Frank, M.B., et al.: Disease-associated pathophysiologic structures in pediatric rheumatic diseases show characteristics of scakle-free networks seen in physiologic systems:implications for psathogenesis and treatment. BMC Med Genomics.<\/i> 2<\/b>: 9, 2009.","DOI":"10.1186\/1755-8794-2-9"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Ravasz, E., et al.: Hierarchical organization of modularity of networks. Science.<\/i> 297<\/b>: 1551-1555, 2002.","DOI":"10.1126\/science.1073374"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Jeong, H., et al.: The large-scale organization of metabolic networks. Nature.<\/i> 407<\/b>: 651-654, 2000.","DOI":"10.1038\/35036627"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Barab\u00e1si, A.-L., et al.: Network medicine: a network-based approach to human illness. Nature Rev Genet.<\/i> 12<\/b>: 56-68, 2011.","DOI":"10.1038\/nrg2918"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Califano, A.: Rewiring makes the difference. Mol Systems Biol.<\/i> 7<\/b>: 463, 2011.","DOI":"10.1038\/msb.2010.117"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Albert, R., et al.: Error and attack tolerance of complex networks. Nature.<\/i> 406<\/b>: 378-382, 2000.","DOI":"10.1038\/35019019"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Jiang, K., et al.: Genomic characterization of remission in juvenile idiopathic arthritis. Arthritis Res Therapy.<\/i> 15<\/b>: R100, 2013.","DOI":"10.1186\/ar4280"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["Using proteomic and genomic methods to understand JDM"],"language":"en","deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:23:28Z","timestamp":1567009408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/3\/38_150\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.150","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}